Search for: "Federal, Inc." Results 121 - 140 of 57,665
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Jul 2022, 9:55 pm by Patent Docs
Noonan -- Almost four years ago, in a relatively rare occurrence based on there being an insufficient factual record to permit proper appellate review, the Federal Circuit vacated a District Court decision rendering invalid the claims in five patents asserted by Tris Pharma, Inc. against Teva Laboratories FL, Inc. and remanded. [read post]
28 May 2020, 7:00 am by Alex Nealon
PalTalk Heads to the Federal Circuit PalTalk Holdings Inc. v. [read post]
16 May 2010, 9:47 pm by Patent Docs
By Donald Zuhn -- Last month, the Court of Appeals for the Federal Circuit decided that the appeal in Therasense, Inc. v. [read post]
14 May 2015, 9:59 pm by Patent Docs
Earlier this week, the Federal Circuit continued this expansion in Classen Immunotherapies, Inc. v. [read post]
10 Nov 2014, 2:18 pm by LTA-Editor
By Miriam Swedlow Apple Inc. recently filed a writ of certiorari with the Supreme Court requesting that the Court review the Federal Circuit’s ruling in Ancora Tech., Inc. v. [read post]
1 Apr 2009, 8:15 am
The federal district court for the Southern District of New York recently dismissed charges against the Meyer Brown law firm in In re Refco, Inc. [read post]
25 Jul 2016, 8:55 pm by Patent Docs
Zillow, Inc., Nextag, Inc., & Adchemy, Inc. [read post]
7 Dec 2023, 9:59 pm by Patent Docs
The issue arose recently before the Federal Circuit in Actelion Pharmaceuticals Ltd. v. [read post]
1 Dec 2015, 9:07 am by WIMS
Court of Appeals, Federal Circuit, Case No. 2014-1725. [read post]
8 Aug 2016, 9:14 pm by Patent Docs
Noonan -- In parallel, nonprecedential decisions regarding litigation over the same patent, the Federal Circuit affirmed a District Court decision that the claims were invalid for indefiniteness under 35 U.S.C. [read post]
1 Sep 2021, 8:10 am by Silver Law Group
The investigation concerns potential violations of the federal securities laws. [read post]
12 Apr 2018, 10:15 pm by Patent Docs
The Federal Circuit had previously held that a petitioner that did not otherwise have Article III standing could not appeal an adverse decision (Phigenix, Inc. v. [read post]